Business · 13/09/2022Updated: 10/17/2026 · 1 min read
FDA Announces Joint Meeting of Advisory Committees for Nonprescription and Obstetrics Drugs
Summary
The Food and Drug Administration (FDA) is hosting a joint meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee to provide advice on regulatory issues, with a public docket for comments
Original source language: Federal Register — Food and Drug AdministrationOpen original release →